We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SEROSEP

Serosep Ltd. is one of Ireland’s leading diagnostics specialists and an innovative, specialist partner of choice for ... read more Featured Products: More products

Download Mobile App





Serosep Exhibits EntericBio System for Testing, Detecting and Identifying GI Pathogens at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022

Serosep Ltd. More...

(Limerick Ireland) is exhibiting its unique system that is revolutionizing molecular testing of gastrointestinal (GI) pathogens at the MEDICA 2022 International Trade Fair being held on November 14-17 in Düsseldorf, Germany. MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals.

At MEDICA 2022, Serosep is exhibiting its EntericBio system which is the market leader in GI realtime PCR testing in the UK/Ireland and provides medium/high throughput labs with a rapid, reliable and easy to use solution for their enteric pathogen testing needs. The EntericBio system is unique as it is capable of detecting target DNA and RNA directly from stool specimens, circumventing the requirement for commercial nucleic acid extraction purification and minimizes hands on time for the laboratory personnel. The EntericBio system provides a complete and flexible modular menu for testing, detecting and identifying GI pathogens including bacteria, parasites, CPE and viruses within the same work-flow and platform with a result for up to 46 specimens per run in les than three hours and results for consecutive runs each hour.

Serosep is also highlighting its comprehensive range of pre-filled Histopot specimen containers for use in histology and pathology laboratories. These biopsy sample containers are manufactured to the highest standard, using quality state of the art production techniques, in a certified manufacturing facility. The HistoPot ensures the safety during patients’ biopsy sample fixation, which is the single most important stage in the histopathology process. The HistoPot is regarded as one of the benchmarks for the fixation and transportation of millions of critical histological samples worldwide.

Related Links:
Serosep Ltd.


New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
POC Immunoassay Analyzer
Procise DX
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. For bipolar disorder, average time to diagnosis can exceed nine years, and... Read more

Molecular Diagnostics

view channel
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.